CAR T-Cells: Refining CLL Therapy With Clinical Trials
2 Views
administrator
07/14/23
Brian Koffman, MDCM, MSEd, shares insight on his current relapse of chronic lymphocytic leukemia (CLL) and discusses the potential value of chimeric antigen receptor (CAR) T-cell therapy, which he will be receiving in an upcoming clinical trial.
View more at http://curetoday.com/
CURE: Combining science and humanity to make cancer understandable.
Show more
Facebook Comments
No comments found